Post exposure prevention of hiv

Details Post exposure prevention of hiv Post exposure prevention of hiv

A - Human Necessities

61

K

A61K 31/70 (2006.01) C07H 19/06 (2006.01)

Patent

CA 2190862

A method of preventing the establishment of HIV infection and/or HIV seroconversion in a human or simian comprising the administration of an effective amount of the compound 1-[2',3'-dideoxy-3'C-(hydroxymethyl)-.beta.-D-eryyhro- pentofuransosyl-cytosine having formula (I) after exposure of said human or simian toHIV..

Méthode prévenant le déclenchement de l'infection due au VIH et/ou la séroconversion chez l'homme et le singe, et consistant à administrer à un patient ou à un singe ayant été exposé au VIH une dose efficace du composé 1-[2',3'-didéoxy-3'C-(hydroxyméthyl)-.beta.-D-érythro-pentofuranosyl]-cytosine de formule (I).

Affiliated with

Also associated with

Rating

Post exposure prevention of hiv does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Post exposure prevention of hiv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Post exposure prevention of hiv will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1537979